课题基金 / 基金详情

Procaspase 3 activator compounds combined with X-ray irradiation

Procaspase 3 activator compounds combined with X-ray irradiation
Procaspase 3 激活剂化合物与 X 射线照射相结合
批准号:
8157743
负责人:
Karl Haglund
金额:
$8.34万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Karl Haglund的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经从伊利诺伊大学的合作者那里获得了两种procaspase 3激活剂(PAC-1和PAC-1),并获得了一组细胞系,用于在x射线照射和不照射的情况下测试化合物。对许多肉瘤细胞系进行的初步实验表明,在低密度下,它们不能形成离散的菌落,这表明评价辐射效应的金标准(菌落形成试验)不能直接应用。我们已经评估了其他几种基于磷酸化γ - h2ax组蛋白的测定方法,以量化在缺乏和存在procaspase 3激活剂的情况下辐射的影响。我们目前正在对每个肉瘤细胞系验证这些检测方法。我们计划在不久的将来继续推进和评估辐射和procaspase 3激活剂药物的任何超加性效应的细胞系面板。
英文摘要
We have obtained two procaspase 3 activators (PAC-1 and sPAC-1) from our collaborators at the University of Illinois, and have obtained a panel of cell lines on which to test the compounds with and without X-irradiation. Initial experiments with a number of sarcoma cell lines showed that they did not form discrete colonies when plated at low density, indicating that the gold standard evaluation of the effects of radiation (colony formation assay) could not be applied directly. We have evaluated several other assays based on phosphorylated gamma-H2AX histone proteins to quantitate the effect of radiation in both the absence and presence of procaspase 3 activators. We are currently validating these assays for each sarcoma cell line. We plan to continue forward and evaluate the panel of cell lines for any supra-additive effects of radiation and procaspase 3 activator drug in the near future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Procaspase 3 activator compounds combined with X-ray irradiation
Therapeutic use of immunomodulators and ionizining radiation
Procaspase 3 activator compounds combined with X-ray irradiation
Sensitization of chordoma cell lines to ionizing radiation
国内基金
海外基金
镍基UNS N10003合金辐照位错环演化机制及其对力学性能的影响研究
冷却包装分割猪肉辐照异味的产生机理及去除方法
  • 批准号:
    10475025
  • 项目类别:
    面上项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2004
  • 负责人:
    林若泰
  • 依托单位: